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 2 
Abstract 21 
Glial support is critical for normal axon function and can become dysregulated in white matter 22 
(WM) disease. In humans, loss-of-function mutations of KCNJ10, which encodes the inward-23 
rectifying potassium channel KIR4.1, causes seizures and progressive neurological decline. We 24 
investigated Kir4.1 functions in oligodendrocytes (OLs) during development, adulthood and after 25 
WM injury. We observed that Kir4.1 channels localized to perinodal areas and the inner myelin 26 
tongue, suggesting roles in juxta-axonal K+ removal. Conditional knockout (cKO) of OL-Kcnj10 27 
resulted in late onset mitochondrial damage and axonal degeneration. This was accompanied by 28 
neuronal loss and neuro-axonal dysfunction in adult OL-Kcnj10 cKO mice as shown by delayed 29 
visual evoked potentials, inner retinal thinning and progressive motor deficits. Axon pathologies 30 
in OL-Kcnj10 cKO were exacerbated after WM injury in the spinal cord. Our findings point 31 
towards a critical role of OL-Kir4.1 for long-term maintenance of axon function and integrity 32 
during adulthood and after WM injury. 33 
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Introduction 38 
Glial support of axons is essential for the maintenance of normal function in the central 39 
nervous system (CNS) (1,2). For example, oligodendrocytes (OLs) maintain metabolic and 40 
trophic support of axons by providing lactate in response to sensing of axonal firing (3-5). 41 
Exchange and buffering of ions such as K+ between astrocytes (AS) and neurons have been well 42 
described and led to the current understanding that those cells are major regulators of neuron 43 
excitability (6-8). However, not much is known about OL-dependent regulation of axonal 44 
excitability through buffering of ions like K+ during action potential propagation. Here, we 45 
focused on Kir4.1 (Kcnj10), a highly conserved ATP- and pH-sensitive K+ channel expressed in 46 
both AS and OL cells of the CNS (9-11). Kir channels regulate K+ transmembrane gradients (12-47 
15), which are critical for action potential propagation as well as axonal K+ outflow that is 48 
necessary to establish resting membrane potential and neuronal repolarization (16-20). Its 49 
complex expression pattern, including homo- and heterotetrameric association with Kir5.1 50 
(Kcnj16), underlies potentially diverse roles depending on glial cell sub-type and CNS 51 
anatomical regions (6-9,21). However, precise functions for Kir4.1 in OLs versus AS are only 52 
poorly understood. 53 
Homotetrameric Kir4.1 is the major inward-rectifying K+ channel in OLs, and its 54 
downregulation has been reported in glial cells in CNS disease (22-24). Because glial Kir4.1 55 
channels help remove extracellular K+ during neuronal activity, general loss-of-function is 56 
associated with severe human neurological conditions. Human congenital KCNJ10 loss-of-57 
function mutations in EAST/SeSAME syndrome cause electrolyte imbalance, seizures, 58 
pathological changes in the retina, sensorineural deafness and progressive motor deficits in 59 
affected individuals (25-28). Prior reports have found early lethality in young adult mice lacking 60 
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glial-Kcnj10, attributable to increased neuronal excitability and epileptic activity (18,21). In 61 
particular, conditional ablation of Kcnj10 using Gfap-cre (that targets both AS and OL glial cell 62 
types) was lethal before P30 (18,29), an early/severe phenotype that precluded study of late 63 
functions in adult white matter (WM). 64 
In contrast to prior studies, we studied the role of OL-Kir4.1 channels in long-term 65 
maintenance of axon function during adulthood and white matter injury focusing on long white 66 
matter tracts, such as the optic nerves and the spinal cord.  We found early and late roles for 67 
Kir4.1 in OL progenitor cells (OPCs) and myelinating OLs using two distinct cre lines to study 68 
age- and disease-related functions during development, adulthood and in the setting of WM 69 
injuries. We observed that Kir4.1 is localized to both OL cell bodies and myelin, where it is 70 
found within the inner tongue of myelin and in AS processes near the node of Ranvier, which 71 
appear poised to remove axonal K+. By dissecting out early from late developmental functions, 72 
we found that OL-Kir4.1 conditional knockout (cKO) was dispensable for early myelin 73 
production but resulted in pronounced late onset axonal degeneration with damage to 74 
mitochondria in long fiber tracts of the optic nerve (ON) and spinal WM as well as after focal 75 
WM demyelination. Hence, our data suggest that K+ clearance via OL-Kir4.1 channels is critical 76 
for sustained axon function and integrity.   77 
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Results 78 
OL-Kir4.1 is gradually upregulated during early postnatal development and shows a peri-79 
axonal expression pattern. As Kir4.1 channels are assembled as homo- and heterotetramers 80 
with Kir5.1, we investigated the expression of both proteins throughout development (9,30). 81 
While in control littermates the number of ON OL-Kir4.1+ channels increased with age (Figure 82 
1A–C), we observed significantly lower Kir4.1 and Kir5.1 protein levels in Kcnj10 cKO mice 83 
expressing cre recombinase under control of the Olig2 promoter (Figure 1A–B; note that 84 
persistent expression corresponds to intact AS Kir4.1 in cKO animals) (31). To study specific 85 
Kir4.1 functions in OLs in vivo, we studied Kcnj10 loss-of-function in OPCs and mature OLs. As 86 
shown (Figure 1D, figure 1 – figure supplement 1A ), Kir4.1 staining was substantially reduced 87 
from Apc+ OL cell bodies but not Gfap+ astrocyte fibers in ON samples from adult Olig2-88 
cre:Kir4.1fl/fl  (cKO-1) and Cnp-cre:Kir4.1fl/fl (cKO-2) mice (Figure 1D) confirming robust 89 
knockout efficiency in OLs (18,31,32). Levels of Kcnj10 transcripts were higher in myelinating 90 
OLs compared to OPCs in vitro, whereas Kcnj16 mRNA decreased during OL maturation 91 
(Figure 1 – figure supplement 1B–C) (33,34). Notably, we observed higher Cacna1c mRNA 92 
levels in the setting of loss-of-OPC-encoded Kcnj10 in-vitro (Figure 1 – figure supplement 1D) 93 
(35,36). Cacna1c encodes Cav1.2, a major voltage-gated Ca2+ channel in OPCs. These findings 94 
demonstrate gradual upregulation of OL-Kir4.1 during postnatal development and suggest a 95 
more critical role of the channel later in life.  96 
To understand spatial expression of OL-Kir4.1 channels in WM tracts, we studied 97 
longitudinal ON and spinal cord sections by high-resolution confocal microscopy and performed 98 
immunogold labeling of Kir4.1 channels in ON sections by electron microscopy (Figure 1E–F). 99 
Using antibodies either against an extracellular or intracellular Kir4.1 epitope, we could 100 
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determine that OL-Kir4.1 channels are localized towards perinodal and juxta-axonal regions such 101 
as the inner tongue of myelin sheaths. Quantification of immunogold particles in ON sections 102 
using the Kir4.1 antibody against the intracellular epitope of the channel revealed a substantial 103 
decrease in inner but not outer tongue labeling in both Olig2-cre and Cnp-cre cKO lines as 104 
compared to controls (Figure 1F, Figure 1 – figure supplement 1E-F).  Using a no-antibody 105 
control labeling, we could confirm specificity of the Kir4.1 labeling to myelin compartments and 106 
astrocyte fibers (Figure 1 – figure supplement 1G).  107 
In WM AS, Kir4.1 immunogold particles were abundant in fibers and particular seen in 108 
processes in contact to the outer myelin tongue, in perivascular end feet and adjacent to the node 109 
of Ranvier (Figure 1F-G). Thus, the age-dependent and specific spatial expression pattern of 110 
glial Kir4.1 channels provides more evidence for a role of those channels in extracellular K+ 111 
buffering during electric activity along WM fiber tracts (Figure 1H). 112 
 113 
OL-Kir4.1 regulates but is not required for OL differentiation and early postnatal 114 
myelination. To investigate a role of OL-Kir4.1 in OL development, we compared OPC 115 
differentiation under control and Kcnj10 loss-of-function conditions. We found that OPCs 116 
lacking Kcnj10 exhibit precocious cell cycle exits as shown by decreased numbers of dividing 117 
cells (Figure 1 – figure supplement 2A–B) and earlier onset of myelin production (Figure 1 – 118 
figure supplement 2C–D). In addition, we found decreased mRNA levels of cell cycle and 119 
progenitor cell markers, such as Uhrf1 and Nkx2-2 in OPCs and conversely observed increased 120 
myelin basic protein (Mbp) mRNA levels in OLs in vitro (Figure 1 – figure supplement 2E–F) 121 
(37). Mice deficient in OL-encoded Kcnj10 had normal g-ratios in ON tissue at P40 (Figure 2A–122 
B); however, they showed slightly smaller g-ratios in spinal WM tracts corresponding to thicker 123 
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myelin sheaths (Figure 2 – figure supplement 1B–C). Axon diameters were not different in both 124 
ON and spinal WM samples at P40 (Figure 2C, figure 2 – figure supplement 1C). The 125 
morphology of intra-axonal mitochondria with respect to circularity and density of mitochondria 126 
was not different in the ON and spinal cord WM between control and Kcnj10 cKO mice at P40 127 
(Figure 2C, figure 2 – figure supplement 1A, D). Notably, the density of mature Apc+ Olig2+ 128 
OLs was transiently higher in Kcnj10 cKO mice at P40, however, normalized during adulthood 129 
(Figure 2D–E). These results suggest that OL-Kir4.1 is involved in regulating cell cycle exit and 130 
OL differentiation during early postnatal development but is not a requirement for normal 131 
myelination. 132 
 133 
OL-Kir4.1 is critical for normal motor and visual function in the adult CNS. We next 134 
investigated roles of OL-Kir4.1 during adulthood for maintenance of WM integrity in Olig2-cre 135 
driven Kcnj10-cKO-1 and Cnp-cre driven Kcnj10-cKO-2 mice and corresponding littermate 136 
controls up to 6 months of age. Both Kcnj10-cKO lines exhibited progressive neurological 137 
symptoms including abnormal gait and ataxia (Video 1), generalized seizures (Video 2) and 138 
hindlimb clasping (Videos 3, 4) starting as early as three months of age. Early lethality by 6 139 
months of age, most likely due to complications of epileptic seizures, was observed in ~70% of 140 
Cnp-cre and ~40% in Olig2-cre driven Kcnj10 cKO mice (Figure 3A) (21). Higher seizure 141 
frequencies were a common feature of both cKO lines with increasing age, in keeping with prior 142 
findings (18,21). All cKO mice showed reduced body weight versus control littermates at P140 143 
(Figure 3B), and we found motor dysfunction as shown by reduced rotarod performance in both 144 
cKO cohorts at P140 (Figure 3C). 145 
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To investigate visual function in live animals, we recorded single-flash light visual 146 
evoked potentials (VEPs) from anesthetized mice to measure conduction along the visual system. 147 
VEP has proven to be a useful method to study ON function in neurological patients with optic 148 
neuritis, such as multiple sclerosis (MS) (38-40). Here, both Kcnj10 cKO lines had delayed VEP 149 
latencies at P140 (Figure 3D–E) indicating dysfunction in the visual system. In addition, we 150 
studied structural changes in the retina of live animals utilizing optical coherence tomography 151 
(OCT), where the thickness of specific retinal layers can be used as a surrogate for retinal 152 
ganglion cell (RGC) survival. Indeed, OCT imaging showed thinning of inner retinal layers 153 
(IRL) in cKO mice at P140 revealing a reduction in the number of ganglion cells and their 154 
corresponding axons (Figure 3F) (41). In summary, permanent loss-of-Kcnj10 function in OLs 155 
results in visual dysfunction with retinal atrophy in adult mice as well as motor deficits and early 156 
mortality. 157 
 158 
OL-Kir4.1 is required for maintenance of WM integrity and late neuronal survival. We 159 
observed decreased Mbp protein levels, a critical myelin component, in ON and spinal cord 160 
lysates from 6-month old Kcnj10 cKO mice, which could explain the delayed VEP latencies 161 
observed in older animals (Figure 4A, figure 4 –  figure supplement 1B–C). A substantial loss 162 
of Kir4.1 protein could be detected in Kcnj10 cKO ON and spinal cord tissue at P180 confirming 163 
robust knockout efficiency at that age (Figure 4A, Figure 4 –  figure supplement 1A-C). 164 
Additionally, at ultrastructural level, we observed disorganization of WM tracts (Figure 4 – 165 
figure supplement 1D) and loss of myelin compactness in a subset of axons as well as evidence 166 
for axonal degeneration in Olig2-cre driven Kcnj10 cKO ON and spinal cord tissue at P140 167 
(Figure 4B, Figure 4 –  figure supplement 1E). Are these results OL-specific or general to glial 168 
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encoded-Kir4.1 function? To address this, we investigated Aldh1l1-cre driven Kcnj10 cKO that 169 
specifically deleted the Kir4.1fl/fl allele in AS of the spinal cord (8). In contrast to findings above, 170 
those AS-specific cKO mice did not show spinal WM tract abnormalities (Figure 4 – figure 171 
supplement 1E) indicating specificity of OL-mediated Kir4.1 functions.  172 
We further characterized WM pathologies and examined mitochondrial morphology in 173 
ON and spinal WM tracts by electron microscopy. At P140, we noted enlarged axons in Olig2-174 
cre driven Kcnj10 cKO ONs (Figure 4B, C) with g-ratios not different between control and cKO 175 
mice (Figure 4 – figure supplement 1F). Densities and total counts of intra-axonal mitochondria 176 
did not change in cKO ONs as compared to controls (Figure 4 – figure supplement 1G). 177 
However, we found evidence for mitochondrial swelling as shown by increased mitochondrial 178 
circularity in Olig2-cre driven Kcnj10 cKO ONs (Figure 4C). Immunostaining for 179 
neurofilaments (NFs) demonstrated loss of normally phosphorylated NFs (P- NF-H, SMI312+) in 180 
cKO ONs (Figure 4D) and an increase in non-phosphorylated NFs (non-P-NF-H, SMI32+) 181 
(Figure 4E), indicative of axon damage and increase in dystrophic axon numbers (42,43). Axon 182 
pathology was accompanied by Iba1+ microglia activation in ONs from Olig2-cre driven Kcnj10 183 
cKO animals (Figure 4F–G) and increased Gfap+ staining (Figure 4F, H). We confirmed loss of 184 
Brn3a+ RGCs through Brn3a staining of retinal whole mount preparations from both Kcnj10 185 
cKO lines at P180 (Figure 4I–J), consistent with the OCT data (see above) indicating retrograde 186 
degeneration along the ON (Figure 4K) (44). In addition, by immunoreactivity retinal Gfap, 187 
Aqp4 and Iba1 levels were not significantly altered (Figure 4 – figure supplement 2A–F). 188 
However, we found increased Kir4.1 immunoreactivity in AS and Müller glia in Olig2-cre 189 
driven Kcnj10 cKO retinae, which could reflect reactive upregulation of Kir4.1 channels in those 190 
glial cells (Figure 4 – figure supplement 2A–B).  Together, these findings demonstrate that OL-191 
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Kir4.1 plays a major role in long-term neuro-axonal maintenance and integrity of long WM 192 
tracts of the ON and spinal cord.  193 
 194 
OL-Kir4.1 is essential for WM integrity after chronic but not acute demyelinating injury. 195 
To study the role of OL-Kir4.1 during acute and chronic remyelination after focal white matter 196 
injury, we utilized the lysolecithin glial toxic injury model in the spinal cord at P80 (45-47). In 197 
the acute situation, 14 days post-lysolecithin-induced focal demyelination of spinal WM tracts 198 
(14 dpl, corresponding to P94), we found that axons in lesions from Olig2-cre driven Kcnj10 199 
cKO animals harbored more mitochondria, which were significantly more swollen/circular than 200 
their control counterparts (Figure 5A-B). However, we observed that early remyelination 201 
efficiency and axon diameters were not altered with similar g-ratios in WM lesions from Olig2-202 
cre driven Kcnj10 cKO mice and control littermates 14 dpl (Figure 5C, Figure 5 – figure 203 
supplement 1A). 204 
In contrast, in chronic lesions 60 days post-lysolecithin lesioning (60 dpl, corresponding 205 
to P140) mitochondrial and axon pathology were readily detectable in Olig2-cre driven Kcnj10 206 
cKO mice with increased numbers of swollen intra-axonal mitochondria (Figure 5D-E) and 207 
enlarged axons (Figure 5F), whereas remyelination as measured by g-ratios was not affected 208 
(Figure 5 – figure supplement 1B) (44).  These results indicate that OL-Kir4.1 is dispensable for 209 
(re)myelination but that its function is crucial for axon support and maintenance after long-term 210 
demyelinating WM injury.  211 
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Discussion 212 
Although support of axons by myelinating oligodendrocytes is an essential requirement 213 
for long-term maintenance of function in the CNS, precise mechanisms of OL-axon trophic 214 
interactions are incompletely understood. Here, we studied the role of OL-Kir4.1 channels for 215 
WM integrity and maintenance in the ON and spinal WM tracts during postnatal development, 216 
adulthood and WM injury. Both fiber tracts are composed of long axons that rely on a strong 217 
glial support establishing proper action potential propagation (1). Long fiber tracts are 218 
particularly vulnerable to WM pathologies as observed in MS and EAST/SeSAME syndrome 219 
(27,40,48), and the anterior visual system comprising the retina and the ON is a common lesion 220 
site in MS. Also, the system is easily accessible to precise imaging and measurements such as 221 
OCT and VEP to monitor neuro-axonal function (48,49).  222 
Interestingly, we found that Kir4.1 channels were localized to perinodal OLs and within 223 
myelin in juxta-axonal spaces along the ON, suggesting roles of Kir4.1 channels for axon 224 
function (9,19,30,33). To our knowledge, this is the first report of a mature OL-associated K+ 225 
channel with polar expression oriented towards axons, i.e. localization at the inner myelin 226 
tongue. Because the lactate transporter MCT1 also shows a similar juxta-axonal expression 227 
pattern (3), it is possible that other ion channels and solute carrier transporters are arrayed in a 228 
similar way to maintain axon energy, activity and integrity.  Thus, we propose that Kir4.1 229 
comprises a ‘myelin nanochannel’. While this positioning is consistent with a role in siphoning 230 
K+ within myelin segments, further studies are needed to confirm this function.   231 
Our loss-of-function studies identified two temporally-regulated roles for OL-Kir4.1. 232 
Using both early-acting Olig2-cre or CNP-cre, which initiates expression at a later stage, we 233 
defined early and later functions of Kir4.1 and ruled out caveats associated with heterozygous 234 
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effects of cre knock in to the Olig2 and Cnp loci (35,50). Regarding early developmental 235 
requirements of OL-Kir4.1 function, the cKO resulted in somewhat precocious maturation and 236 
myelination. This suggests either a direct role in regulating differentiation or indirect effects of 237 
altered ion currents on voltage-gated Ca2+ channels in Kcnj10-deficient OPCs (35,36,50). Based 238 
on observations during development and regeneration, we conclude that Kir4.1 regulates, but is 239 
not required for normal myelination. Other studies have indicated early roles for OL-Kir4.1 240 
channels in support of acute axonal activity (21). 241 
Secondly, we studied late (adult) functions of glial Kir4.1 and identified a specific OL-242 
related role of Kir4.1 channels for support of long axons of the ON and the spinal WM. Indeed, 243 
our data demonstrated that OL-mediated Kir4.1 function was essential in WM maintenance, a 244 
function not found in AS-specific Kcnj10 cKO mice (8).  While in principle, loss of OL-Kir4.1 245 
currents can be compensated for by OPC- or AS-encoded Kir4.1/Kir5.1 channels, or 246 
homotetrameric Kir5.1 channels with PSD-95 (11,51), it is evident that such compensation 247 
eventually fails during adulthood in OL-specific Kcnj10 cKO mice, possibly due to increasing 248 
demand for perinodal K+ buffering during sustained electric activity, such as with physical 249 
exertion (rotarod performance) or after (excitotoxic) demyelinating WM injury. Indeed, we 250 
found that Kir4.1 (Kcnj10) expression increases in OLs during maturation and aging, and 251 
consistent with progressive requirements in adults, it has been reported that Kir4.1-mediated K+ 252 
buffering becomes more important during ON high-frequency stimulation and that OL-Kcnj10 253 
loss-of-function increases neuronal excitability in adult mice (19,21). In contrast, mice without 254 
AS-encoded Kcnj10 lack spinal WM tract abnormalities typical of OL-encoded Kir4.1 cKO 255 
mice. Thus, our data parses out the specific roles of OL-Kir4.1 and reveals a new supportive role 256 
of OLs for long-term axon maintenance. 257 
 13 
Thus, our findings suggest a model in which developmental upregulation of OL-Kir4.1 is 258 
linked to increasing needs for axonal K+ homeostasis during adulthood. Siphoning of K+ is most 259 
likely established through an orchestrated action of juxta-axonal and perinodal glial Kir4.1 260 
channels. The ad-axonal expression pattern of mature OL-Kir4.1 channels emphasizes that those 261 
channels might have an essential role in K+ clearance from axons, a function that becomes more 262 
critical later in life. However, we cannot rule out other distinct functions of Kir4.1 that are more 263 
linked to cell body-associated localization of Kir4.1 and OL-intrinsic functions like 264 
differentiation during early postnatal development (see above).  Indeed, motor dysfunction and 265 
spastic paraplegia are progressive age-related neurological symptoms in individuals with 266 
EAST/SeSAME syndrome (26), which would resemble features that come with permanent 267 
knockout of mature OL-Kir4.1 channels resulting in mitochondrial damage and progressive 268 
neurodegeneration. Increased numbers and swelling of mitochondria as well as enlarged axon 269 
diameters were early indicators of impending axonal degeneration in OL-Kcnj10 cKO mice, 270 
especially when challenged with focal WM demyelination. Of note, morphological changes of 271 
intra-axonal mitochondria have been associated with lysolecithin-induced demyelinating lesions 272 
(52,53) and axonal degeneration in experimental autoimmune encephalomyelitis (EAE), an 273 
animal model of MS (54). In the latter, it might characterize a phenomenon that is reversible and 274 
precede ultimate axonal degeneration. Notably, higher seizure frequencies with increasing age 275 
might contribute to chronic cognitive and motivational dysfunction in cKO animals; however, it 276 
is unlikely that this has a major effect on degenerative changes in long white matter tracts. 277 
In summary, we identified that OL-Kir4.1 channels are localized to myelin inner tongue 278 
and juxta-nodal regions suggesting functions in removal of K+ commensurate with axonal 279 
activity. Moreover, we describe a novel role for OL-encoded Kcnj10 in long-term maintenance 280 
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of axons in WM tracts of the CNS. Permanent loss of OL-Kir4.1 channels resulted in progressive 281 
damage to axons and ultimately loss of neurons with increasing age. Our findings raise the 282 
question of whether similar mechanisms might exist in Schwann cells that serve the myelinating 283 
function in the peripheral nervous system. Additionally, our finding might have relevance for 284 
understanding mechanisms of axonal degeneration in chronic MS lesions, where KIR4.1 285 
channels are dysregulated and lost during lesion progression (24). If so, dissecting mechanisms 286 
of dysregulated K+ homeostasis in chronic neuro-inflammatory conditions could help develop 287 
neuroprotective strategies designed to correct local peri-axonal K+ imbalances.288 
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Figure Legends 314 
Figure 1. OL-Kir4.1 is upregulated during postnatal development and localized to peri-315 
axonal spaces. Kir4.1 ON protein levels were upregulated between age P40 and P140, whereas 316 
Kir5.1 protein levels did not change during aging (A–B). Note substantial loss of Kir4.1 protein 317 
in Olig2-cre driven Kcnj10 cKO (cKO-1) mice at P40, which became more apparent at P140; 318 
Kir5.1 protein was also reduced in cKO-1 ONs at P40 and P140 (control and cKO-1: n = 3 for all 319 
time points) (A–B). Quantification of Kir4.1+ Apc+ OLs confirmed age-dependent upregulation 320 
of OL-Kir4.1 channels between P40 and P140 (n = 4 for all time points) (C). One-way ANOVA 321 
with Tukey’s multiple comparison tests were performed in B and C; *P ≤ 0.05, **P ≤ 0.01, ***P 322 
≤ 0.001, ****P ≤ 0.0001. Kir4.1 channels were lost from both ON OL cell bodies in cKO-1 and 323 
Cnp-cre driven Kcnj10 cKO (cKO-2) mice versus controls (D). Note that Kir4.1+ OL are marked 324 
by magenta-colored arrowhead; Apc+ OLs are indicated by green arrowheads. Note AS Kir4.1 325 
immunoreactivity and contacts of Kir4.1+ AS fibers with OLs (white arrowheads). Merged 326 
images are shown in panels highlighted by yellow surroundings (D). Kir4.1 was strongly 327 
expressed in OLs along spinal fiber tracts; green arrowheads mark Apc+ OLs and cyan-colored 328 
arrowheads mark juxta-axonal Kir4.1 IR (E). Kir4.1 immunogold electron microscopy (IEM) 329 
labeling revealed presence of gold particles at inner and outer myelin tongue (cyan-colored 330 
arrowheads) and within AS fibers (magenda-colored arrowheads) adjacent to myelin sheaths (M 331 
= myelin) and blood vessels (BV = blood vessel; ctrl: n = 3, cKO-1: n = 3; F–G). Axon 332 
structures are highlighted in yellow, AS fibers are highlighted in magenta. Note decrease in inner 333 
tongue (F) but not compact myelin (F) or AS fiber (G) IEM labeling in cKO-1 ON tissue versus 334 
controls. Cartoon highlights proposed mechanism of glial K+ siphoning from axons during 335 
saltatory conduction towards blood vessels via a network of axonal Kv and glial Kir4.1 channels 336 
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(H). Mann-Whitney tests were performed in F–G; ***P ≤ 0.001, p = 0.06 (F, compact myelin 337 
IEM), p = 0.74 (G, AS fiber IEM). Data are presented as mean ± s.e.m in B–C and F–G. 338 
 339 
Figure 2. OL-Kir4.1 regulates early OL differentiation but is dispensable for myelination. 340 
Early developmental loss of OL-Kcnj10 did not affect myelin sheath thickness or axon diameters 341 
in ONs from animals at P40 (210 axons from 4 control mice, 202 axons from 4 cKO-1 mice; A–342 
C). Densities of intra-axonal mitochondria were not different between control and cKO-1 ONs at 343 
P40 (81 axons from 4 control mice, 77 axons from 4 Kcnj10 cKO-1 mice; C). Mann-Whitney 344 
test was performed in B–C; p = 0.49 (g-ratios, B), p = 0.89 (axon diameter, C) and p = 0.89 345 
(mitochondria density, C).  Immunostaining for Olig2 (pan-lineage marker for OPC/OL cells) 346 
and Apc (OL maturation marker) demonstrated precocious OL differentiation in cKO-1 ONs at 347 
P40 versus P80 and P140 (D–E). Two-way ANOVA with Sidak’s multiple comparison test was 348 
performed in E; **P ≤ 0.01. Data are presented as mean ± s.e.m in B, C and E. 349 
 350 
Figure 3. OL-Kir4.1 controls motor performance and visual function in adult mice. Mice 351 
lacking OL-Kir4.1 channels had increased mortality with survival rates of 96% in the control 352 
group (n = 29), 54% in cKO-1 (n = 13) and only 33% in cKO-2 (n = 9) mice at P180 (A). Log-353 
rank (Mantel-Cox) test was performed and p-value shown in A. Kcnj10 cKO-1 (n = 10) and 354 
cKO-2 (n = 9) mice were significantly smaller than control littermates (n = 30) at P140 (B). 355 
Kruskal-Wallis with Dunn’s multiple comparisons test was performed in B; **P ≤ 0.01, ***P ≤ 356 
0.001.  Motor dysfunction with reduced rotarod performance has been observed in both cKO-1 357 
(n = 7) and cKO-2 (n = 7) mice as compared to controls (n = 21) (C). Two-way ANOVA with 358 
Tukey’s multiple comparisons test was performed in C; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, 359 
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****P ≤ 0.0001.  Visual function was measured by single-flash light VEP recordings from 360 
control and Kcnj10 cKO mice (D–E). VEPs were delayed in cKO-1 (n = 7) and cKO-2 (n = 4) 361 
mice versus controls (n = 14) (E). Kruskal-Wallis with Dunn’s multiple comparisons test was 362 
performed in E; *P ≤ 0.05.  Retina integrity was measured by OCT imaging at P140 and 363 
revealed IRL thinning in cKO-1 (n = 5) and cKO-2 (n = 4) mice as compared to controls (n = 15; 364 
F). Kruskal-Wallis with Dunn’s multiple comparisons test was performed in F; *P ≤ 0.05, ***P 365 
≤ 0.001.  366 
 367 
Figure 4. OL-Kir4.1 has a critical role in WM integrity and long-term maintenance. Myelin 368 
basic protein (Mbp) was decreased in ON lysates from cKO-1 (n = 4) mice versus controls (n = 369 
4) at P180 (A). Mann-Whitney test was performed in A; *P ≤ 0.05. Transmission electron 370 
microscopy demonstrated WM pathology with presence of degenerating (highlighted in yellow) 371 
and damaged axons of mild (highlighted in blue) and more pronounced severity (green highlight) 372 
at P140 (B). Axons were larger in cKO-1 versus control ONs at P140 (146 axons from 4 control 373 
mice, 139 axons from 4 cKO mice; C). Intra-axonal mitochondria were more circular as a proxy 374 
for swelling and dysfunction in cKO-1 mice ONs as compared to controls at P140 (86 axons 375 
from 4 control mice, 73 axons from 4 cKO mice; C). Mann-Whitney tests were performed in C; 376 
*P ≤ 0.05. Numbers of physiological SMI312+ (phosphorylated neurofilaments) axon profiles 377 
were reduced in ONs from cKO-1 (n = 5) and cKO-2 (n =4) versus controls (n =5; D), and 378 
numbers of dystrophic SMI32+ (non-phosphorylated neurofilaments) axons were increased in 379 
ONs from cKO-2 (n =4) versus control (n =5) and cKO-1 (n = 5) mice (E). Kruskal-Wallis with 380 
Dunn’s multiple comparisons tests were performed in D and E; **P ≤ 0.01, ***P ≤ 0.001, ****P 381 
≤ 0.0001.  Iba1+ microglia activation was a common feature in ONs from cKO-1 (n = 5) and 382 
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cKO-2 (n =4) versus control (n = 5) mice (F–G). Kruskal-Wallis with Dunn’s multiple 383 
comparisons test was performed in G; *P ≤ 0.05.  Note microglial cell (highlighted in magenta) 384 
adjacent to dystrophic axons in cKO-1 ON (F). Astrogliosis as indicated by increased Gfap IR 385 
was enhanced in cKO-1 (n = 5) and cKO-2 (n =4) ONs versus controls (n = 5) (H). One-way 386 
ANOVA with Tukey’s multiple comparison test was performed in H; *P ≤ 0.05, ***P ≤ 0.001. 387 
Reduced densities of Brn3a+ RGCs in cKO-1 (n = 7) and cKO-2 (n = 2) versus control mice (n = 388 
10) were indicative of retrograde retinal neurodegeneration (I–J). Kruskal-Wallis with Dunn’s 389 
multiple comparisons test was performed in J; *P ≤ 0.05.  Cartoon highlights pathological 390 
changes in the retina of Kir4.1 cKO versus control mice with retrograde “dying back” 391 
degeneration of RGCs and compensatory upregulation of Kir4.1 in retinal glial cells of Kcnj10 392 
cKO mice (K). Data are presented as mean ± s.e.m in A, C, D–E, G–H and J. 393 
 394 
Figure 5. OL-Kir4.1 is dispensable for remyelination, but critical for long-term axon 395 
maintenance after WM demyelinating injury. OL-Kir4.1 function was studied in short- (A–C) 396 
and long-term remyelination (D–F) after lysolecithin-induced focal demyelination to 397 
ventrolateral spinal WM tracts. Mice were euthanized and perfused at two survival time points 398 
corresponding to days post lesioning (dpl, n = 4 for each time point and genotype): 14 dpl 399 
(corresponding to P94, representing new myelin sheath formation) and 60 dpl (corresponding to 400 
P140, full remyelination). Densities of intra-axonal mitochondria were increased in cKO-1 (176 401 
axons from 4 mice) versus control animals (230 axons from 4 mice) at 14 dpl and 402 
circularity/swelling of intra-axonal mitochondria was higher in cKO-1 (79 axons from 4 mice) 403 
versus controls (141 axons from 4 mice; A-B). Note high-magnification images of representative 404 
mitochondria in A indicating enlarged mitochondria in axons from cKO-1 versus control 405 
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lesioned tissue. Conversely, loss of OL-Kir4.1 did not affect g-ratios and axon diameters in cKO-406 
1 (176 axons from 4 mice) versus control mice (230 axons from 4 mice) (C). At 60 dpl, cKO-1 407 
mice exhibited pronounced WM damage during long-term remyelination with presence of 408 
enlarged and degenerating axons (highlighted in green and yellow) as well as increased numbers 409 
of swollen intra-axonal mitochondria (D). Numbers of intra-axonal mitochondria were increased 410 
in cKO-1 versus control mice 60 dpl but densities of mitochondria were not different due to 411 
enlargement of lesion axons and thus relative lower mitochondria densities in cKO-1 axons; 412 
intra-axonal mitochondria were more circular in cKO-1 (90 axons from 4 mice) mice as 413 
compared to controls (88 axons from 4 mice) at 60 dpl (E). Remyelination was efficient and not 414 
different between cKO-1 (139 axons from 4 mice) and control mice (152 axons from 4 mice) at 415 
60 dpl, however, enlarged axons were observed in cKO-1 mice as compared to controls (F). 416 
Mann-Whitney tests were performed in B–C and E–F; *P ≤ 0.05, p = 0.69 (C). Data are 417 
presented as mean ± s.e.m in B–C and E–F. 418 
 419 
Figure 1 – figure supplement 1. Kir4.1 channels were efficiently ablated from ON OLs in cKO-420 
1 (n = 5) and cKO-2 (n = 4) mice versus control ONs (n = 5; A). One-way ANOVA with 421 
Tukey’s multiple comparisons test was performed in A; ****P ≤ 0.0001. Kcnj10 was 422 
upregulated during OL differentiation, and expression significantly suppressed in purified and 423 
immunopanned OPCs (ctrl: n = 3, cKO-1: n = 3) and OLs (ctrl: n = 3, cKO-1: n = 3) from cKO-1 424 
mice (B). Conversely, Kcnj16 was not downregulated in OPCs (ctrl: n = 3, cKO-1: n = 3) and 425 
OLs (ctrl: n = 3, cKO-1: n = 3) from cKO-1 mice in vitro, however, note Kcnj16 downregulation 426 
during OPC-OL maturation (C). Cacna1c mRNA levels were increased in cultured OPCs (ctrl: n 427 
= 3, cKO-1: n = 3) but not OLs (ctrl: n = 3, cKO-1: n = 3) from cKO-1 mice suggesting a partial 428 
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activation of Cav1.2 channels in OPCs (D). One-way ANOVA with Tukey’s multiple 429 
comparison tests were performed in B–D; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. 430 
No difference in outer tongue Kir4.1 IEM labeling between controls and ON cKO-1 tissue (E). 431 
Trend towards decreased Kir4.1 IEM labeling in cKO-2 ON tissue as compared to controls with 432 
respect to myelin compartments but not AS fibers (F). Background IEM labeling without 433 
primary antibody confirmed specificity of Kir4.1 IEM antibody labeling of myelin compartments 434 
and astrocyte fibers (G).  Mann-Whitney tests were performed in E–G; ****P ≤ 0.0001, p = 0.8 435 
(E, outer tongue IEM), p = 0.07 (F, inner tongue IEM), p = 0.6 (F, compact myelin IEM), p = 436 
0.3 (F, outer tongue IEM), p = 0.81 (F, AS fiber IEM), p = 0.12 (G, compact myelin IEM), p = 437 
0.08 (G, outer tongue IEM), p = 0.03 (G, AS fiber IEM). Data are presented as mean ± s.e.m in 438 
A–G. 439 
 440 
Figure 1 – figure supplement 2. Kcnj10-deficient OPCs exhibited less BrdU incorporation in 441 
spinal cord tissue of P1 mice suggesting precocious exit from the cell cycle (ctrl: n = 4, cKO-1: n 442 
= 4; A). Likewise, purified and immunopanned Kcnj10-deficient OPCs exhibited less EdU 443 
incorporation but no difference in the mitosis marker phospho-histone H3 (pH3) in-vitro (ctrl: n 444 
= 3, cKO-1: n = 3; B). cKO-1 mice showed enhanced myelination in spinal cord WM at P1 by 445 
Mbp IHC (ctrl: n = 4, cKO-1: n = 4; C), and Kcnj10-deficient OLs showed more myelination 446 
during differentiating culture conditions in-vitro (ctrl: n = 4, cKO-1: n = 4; D). Mann-Whitney 447 
tests were performed in A–D; *P ≤ 0.05, ***P ≤ 0.001. Transcript levels for Cdk1 and Cdk2 448 
were not different between control and Kcnj10-deficient OPCs in-vitro, whereas mRNA levels 449 
for Uhrf1 and Nkx2-2 were reduced in Kcnj10-deficient OPCs (ctrl: n = 3, cKO: n = 3; E). Note 450 
transcript levels for Nkx2-2 and Cnp were not different between control and Kcnj10-deficient 451 
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OLs in-vitro after switching to differentiating culture conditions, however, Mbp mRNA levels 452 
increased in Kir4.1-deficient OPCs (ctrl: n = 3, cKO-1: n = 3; F). Multiple t tests were performed 453 
in E–F; **P ≤ 0.01, ***P ≤ 0.001; E: p = 0.25 (Cdk1), p = 0.88 (Cdk2) and F: p = 0.97 (Nkx2-2), 454 
p = 0.42 (Cnp). Data are presented as mean ± s.e.m in A–F. 455 
 456 
Figure 2 – figure supplement 1. Intra-axonal mitochondria did not differ with respect to 457 
circularity and numbers per individual axon between ON tissue from control and cKO-1 mice 458 
(210 axons from 4 control mice, 202 axons from 4 cKO-1 mice; A). Mann-Whitney test was 459 
performed in A; p = 0.31 (mitochondria circularity) and p = 0.69 (mitochondria counts/axon).  In 460 
line with ON results, spinal cord WM axon diameters and intra-axonal mitochondrial parameters 461 
(density, numbers/axon) were not different between cKO-1 mice and control littermates at P40 462 
(191 axons from 4 control mice, 193 axons from 4 cKO-1 mice; (B–D). Of note, g-ratios were 463 
slightly smaller in cKO-1 mice corresponding to thicker myelin sheaths in spinal cord axons at 464 
P40. Mann-Whitney tests were performed in A and C–D; *P ≤ 0.05, p = 0.31 (mitochondrial 465 
circularity, A), p = 0.2 (mitochondria counts/axon, A), p = 0.68 (axon diameters, C), p = 0.49 466 
(mitochondria density, D), p = 0.2 (mitochondria counts/axon, D). Data are presented as mean ± 467 
s.e.m in A and C–D. 468 
 469 
Figure 4 – figure supplement 1. Note Kir4.1 protein levels were significantly reduced in ONs 470 
from cKO-1 mice at P180 (ctrl: n = 4, cKO-1: n = 4; A). Likewise, Kir4.1 protein levels were 471 
substantially decreased in spinal cord tissue from cKO-1 mice at P180 (B–C); note that Mbp 472 
protein levels are slightly reduced, but not significantly different between control and OL-Kir4.1 473 
cKO-1 animals (ctrl: n = 4, cKO-1: n = 4; B–C); Mann-Whitney tests were performed in A and 474 
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C; *P ≤ 0.05, p = 0.06 (Mbp, C). Representative toluidine blue staining of spinal WM in control 475 
and cKO-1 at P140 (D); note disorganized WM tracts in Kir4.1 cKO mice. By electron 476 
microscopy, dystrophic myelin and altered axonal integrity was observed in spinal WM tracts of 477 
OL-specific cKO-1 but not in control or AS-specific Kcnj10 cKO (Aldh1l1-cre) mice (E). At 478 
P140, g-ratios (146 axons from 4 control mice, 139 axons from 4 cKO-1 mice), densities and 479 
counts of intra-axonal mitochondria (73 axons from 4 control mice, 86 axons from 4 cKO-1 480 
mice) were not altered in ONs between control and cKO-1 mice (F–G). Mann-Whitney tests 481 
were performed in F–G; p = 0.18 (g-ratios, F), p = 0.23 (mitochondrial densities, G) and p = 482 
0.20 (mitochondria/axon, G).  483 
 484 
Figure 4 – figure supplement 2. Cartoon shows cross-section of inner retinal layers with glial 485 
cells expressing Kir4.1; note that Kir4.1 immunoreactivity was increased in inner retinal layers 486 
of cKO-1 mice at P180 (A–B). Conversely, IRs for Gfap (A–B), Aqp4 (C–D) and Iba1 (E–F) 487 
were not different in retinal layers between control and cKO-1 mice at P180 (ctrl: n = 3, cKO: n 488 
= 3; A–F). Mann-Whitney tests were performed in B, D and F; *P ≤ 0.05, p = 0.1 (Gfap, B), p = 489 
0.2 (Aqp4, D), p = 0.7 (Iba1, F). Data are presented as mean ± s.e.m in B, D and F.  490 
 491 
Figure 5 – figure supplement 1. No differences in g-ratios were observed in early (14dpl) and 492 
late (60dpl) remyelinating white matter lesions from control and cKO-1 mice. Mann-Whitney 493 
tests were performed in A and B; p = 0.34 (A and B). Data are presented as mean ± s.e.m in A 494 
and B. 495 
 496 
Video 1. Ataxia and motor dysfunction are progressive symptoms in OL-Kcnj10 cKO mice. 497 
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Video shows gait ataxia in OL-Kcnj10 cKO mouse (left) as compared to littermate control (right) 498 
at P140. 499 
 500 
Video 2. Seizures are common and progressive in adult OL-Kcnj10 cKO mice. Video shows 501 
generalized seizure in OL-Kcnj10 cKO mouse at P140. 502 
 503 
Videos 3 and 4. Hind limb clasping is characteristic for adult OL-Kcnj10 cKO mice. Video 504 
3 shows hind limb clasping as typical sign of motor dysfunction in OL-Kcnj10 cKO mice 505 




Mice. All mouse strains were maintained at the University of California, San Francisco (UCSF) 509 
specific pathogen-free animal facility under protocol number AN110094. All animal protocols 510 
were approved by and in accordance with the guidelines established by the Institutional Animal 511 
Care and Use Committee and Laboratory Animal Resource Center. Kir4.1fl/fl mice were obtained 512 
from Ken D. Mc Carthy (University of North Carolina, Chapel Hill, NC, USA) and generated as 513 
previously described (8,18). Olig2-tva-cre transgenic mice were generated as previously 514 
described (31). Cnp-cre transgenic mice were commercially available and previously generated 515 
(Jackson Lab) (32). Aldh1l1-cre mice were generated by the GENSAT project as previously 516 
described (55). All mice were maintained on a 12 hours light/dark cycle with food and water 517 
available ad libitum. All Mice were kept on a C57BL/6 background and Kir4.1fl/fl littermate 518 
controls were used for all experiments. 519 
Behavioral analysis. All behavioral experiments were performed at the UCSF Neurobehavioral 520 
Core for Rehabilitation Research. Rotarod (Ugo Basile) testing was performed on a rotating rod 521 
that accelerated from 0-40 rotations per minute (rpm) in during a 5-minute period. The latency to 522 
fall (in seconds) was recorded for each mouse in order to assess for motor deficits and 523 
endurance. Animals were tested three times per day for three consecutive days. 524 
Optical coherence tomography. Retinal in-vivo imaging using optical coherence tomography 525 
(OCT) was carried out as previously described (56,57). Briefly, pupils were dilated with 1% 526 
tropicamide (Akorn), and mice were anesthesized using isoflurane (Isothesia, Henry Schein 527 
Animal Health). Guided by the infrared fundus image, vertical and horizontal OCT scans 528 
confirmed that the retina lays perpendicular to the laser. Then, 25 B-scans in high-resolution 529 
mode were taken and rasterized from 30 averaged A-Scans using the Spectralis Diagnostic 530 
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Imaging system with the TruTrack eye-tracker to avoid motion artifacts (Heidelberg 531 
Engineering). Automated segmentation was done using the modular imaging software 532 
(Heidelberg Eye Explorer). Retinal segments were manually corrected corresponding to the inner 533 
limiting membrane (ILM) and inner plexiform layer (IPL), representing the limits of the inner 534 
retinal layers (IRL). IRL thicknesses were calculated using the Early Treatment Diabetic 535 
Retinopathy Study (ETDRS) grid with diameters of 1, 2, and 3mm centered on the optic disc, 536 
and exported into a spreadsheet file. Both eyes for each mouse were examined, using generalized 537 
estimating equations with an exchangeable correlation matrix and adjustments for intra-subject 538 
inter-eye correlations(41). All experiments were carried out by an operator blinded for mouse 539 
genotype and treatment condition. 540 
Visual evoked potentials. Visual pathway conduction was examined by recording of flash-light 541 
visual evoked potentials (VEP) using an Espion Diagnosys setup (Diagnosys). Mice were 542 
anesthetized using xylazine (20mg/ml, Anased, Akorn) and ketamine (100mg/ml, Ketathesia, 543 
Henry Schein Animal Health) in sterile 0.1M PBS through intraperitoneal (i.p.) injection. Mice 544 
were adapted to darkness for 5 minutes before placed in the recording system. The measuring 545 
electrode was a needle electrode placed medially in the area corresponding to the visual cortex, 546 
the reference electrode was placed under the nasal skin, while the grounding was positioned at 547 
the tail root. VEP recordings started 13 minutes after i.p. injection and consist of three runs 548 
(3cd·s/m2, 1 Hz, 4ms, 6500K, 100 sweeps). Mice VEP results in a negative wave, corresponding 549 
to P100 in humans, after approximately 75ms, called N1. After three recordings per mouse were 550 
collected, the latency was calculated as the average of the 2nd and 3rd N1 result. All experiments 551 
were carried out by an operator blinded for mouse genotype and treatment condition.  552 
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Oligodendrocyte progenitor cell cultures. Isolation and purification of mouse OPCs was 553 
performed according to previously described immunopanning protocols using an anti-Pdgfra 554 
(CD140a) antibody for positive selection of OPCs (58-60). Briefly, OPCs were immunopanned 555 
from P7-P9 mouse cortices and plated on poly-D-lysine coverslips (Neuvitro). Cells were kept in 556 
proliferation media (PDGF-AA, CNTF, and NT3; Peprotech) at 10% CO2 and 37°C. After two 557 
days in proliferation media, differentiation was induced by changing media to contain CNTF and 558 
triiodothyronine (T3; Sigma).  Note that mycoplasma contamination testing was negative. 559 
Focal white matter demyelinating injury. Mice were anesthetized using xylazine (20mg/ml, 560 
Anased) and ketamine (100mg/ml, Ketathesia) in sterile 0.1M PBS through i.p. injection. Focal 561 
demyelinating WM lesions were induced in the lower thoracic spinal cord around T12/13 562 
according to previously published protocols (45,46). Briefly, 1µL of 1% lysolecithin (l-a-563 
lysophosphatidylcholine, Sigma) were injected to induce focal WM demyelination in the 564 
ventrolateral spinal cord of P80 cKO and control littermate mice.  565 
Mouse tissue immunohistochemistry. Mice were deeply anesthetized and transcardially 566 
perfused with ice-cold phosphate-buffered saline (PBS) followed by 4% paraformaldehyde 567 
(PFA) and subsequently post-fixed in PFA for 1 hour. After post-fixation, samples were 568 
cryoprotected in 30% sucrose in PBS for 48 hours at 4°C and embedded in optimal cutting 569 
temperature (OCT) compound (Tissue-Tek). 16 µm-cryosections were collected on superfrost 570 
slides (VWR) using a CM3050S cryostat (Leica) and fixed in either 4% PFA at room 571 
temperature (RT) or ice-cold methanol. Sections were blocked in 0.1M PBS/0.1% Triton X-100/ 572 
10% goat/horse/donkey sera for 1 hour at RT. Primary antibody incubations were carried out 573 
overnight at 4°C. After washing in 0.1M PBS, cryosections were incubated with secondary 574 
antibodies diluted in 0.1M PSB/ 0.1% Triton X-100 for 2 hours, RT. For immunofluorescence, 575 
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Alexa fluochrome-tagged secondary IgG antibodies (1:500, Invitrogen) were used for primary 576 
antibody detection. Slides with fluorescent antibodies were mounted with DAPI Fluoromount-G 577 
(SouthernBiotech). Negative control sections without primary antibodies were processed in 578 
parallel.  579 
Transmission electron microscopy. Tissue processing and image acquisition by transmission 580 
electron microscopy (EM) was carried out as previously reported (61). Briefly, mice were 581 
perfused transcardially with 0.1M PSB followed by 4% glutaraldehyde and 0.008% CaCl2 in 582 
0.1M PBS. After post-fixation in glutaraldehyde, ON and spinal cord tissue blocks were further 583 
fixed in osmium tetroxide at 4°C overnight, dehydrated through ascending ethanol washes, and 584 
embedded in TAAB resin (TAAB Laboratories). 1 μm-thick sections were cut, stained with 585 
toluidine blue, and examined by light microscopy to assess WM integrity and identify lesions. 586 
Non-lesion ON, spinal cord and remyelinating lesion blocks were examined by transmission EM 587 
(Hitachi, H600), and g-ratio calculations of axons in the area of interest were calculated by 588 
dividing the diameter of an axon by the diameter of axon and associated myelin sheath. Between 589 
100–200 axons per group of 4 animals were analyzed. Briefly, images of transverse ON and 590 
spinal cord sections were taken at either 6,000x or 10,000x magnification. Digitized and 591 
calibrated images were analyzed, and linear regression was used to indicate the differences 592 
between cKO and control groups in myelin thickness across the range of axon diameters. 593 
Numbers and densities of intra-axonal mitochondria per axon area were quantified, and 594 
circularities of individual mitochondria were calculated using Fiji ImageJ software (NIH). 595 
Circularity is a two-dimensional sphericity index with a value of 1 corresponding to a perfect 596 
sphere: Circularity=4π×Area/(Perimeter)2. 597 
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Immunoelectron microscopy. Briefly, mice at the age of 6 months were perfused with 4 % 598 
formaldehyde and 0.2 % glutaraldehyde in 0.1 M phosphate buffer containing 0.5 % NaCl. ONs 599 
were dissected and postfixed in the same fixation solution for 24 hours. Small pieces of ON 600 
tissue were embedded in 10 % gelatine and subsequently infiltrated with 2.3 M sucrose in 0.1 M 601 
phosphate buffer overnight. Small blocks of gelatine containing the ON pieces were mounted on 602 
aluminum pins for ultramicrotomy and frozen in liquid nitrogen. Ultrathin cryosections were 603 
prepared with a 35° cryo-immuno diamond knife (Diatome) using a UC7 cryo-ultramicrotome 604 
(Leica). For immuno-labeling sections were incubated with antibodies directed against either 605 
intracellular or extracellular epitopes of Kir4.1, which were detected with protein A-gold (10nm) 606 
obtained from the Cell Microscopy Center, Department of Cell Biology, University Medical 607 
Center Utrecht, The Netherlands. Sections were analyzed with a LEO EM912AB (Zeiss), and 608 
digital micrographs were obtained with an on-axis 2048x2048-CCD camera (TRS) (62). For 609 
quantification of immunogold labeling, 11 images with a size of 8 µm x 8 µm per animal were 610 
obtained from one optic nerve section in a systematic random sampling regime. The total 611 
analyzed field of view covers 704 µm2 per animal. Of each genotype, 3 animals were analyzed 612 
after labeling with the antibody against the intracellular epitope of Kir4.1 (APC-035, Alomone 613 
labs) including a reagent control by omitting the primary antibody. All gold particles were 614 
counted and assigned to structures identified by morphology such as astrocyte profiles, compact 615 
myelin, myelin inner and outer tongue. 616 
Whole-mount immunohistochemistry. Retinal whole-mount preparations were performed from 617 
eyes that were post-fixed in 4% PFA for additional 24 hours after intracardial perfusion. 618 
Afterwards, eyes were kept in PBS, and retinal whole mounts were prepared as described 619 
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previously (57). Retinal ganglion cells were stained with an anti-Brn3a antibody and quantified 620 
using the Fiji ImageJ software. 621 
Immunocytochemistry. Proliferating OPCs were quantified by immunoreactivity for EdU or 622 
pH3. Stainings were performed on day 3 after immunopanning and one day after replacement of 623 
proliferating media. Mbp immunostaining was performed to quantify myelinating OLs after 624 
switching to differentiating culture conditions as previously described (58).  625 
Proliferation assays. P1 pups were injected with 10 mg/ml Bromodeoxyuridine (BrdU) i.p. (BD 626 
Pharmingen). After two hours, mice were intracardially perfused. After tissue processing and 627 
cryo-sectioning, DNA on sections was denatured by incubation in 2N HCl for 30 minutes at 628 
37°C, followed by rinses with 0.1M boric buffer. Then, BrdU incorporation was visualized 629 
performing IHC using an anti-BrdU antibody. For in-vitro proliferation studies, cells were 630 
incubated with 5-ethynyl-2´-deoxyuridine (EdU) for 1 hour, and EdU incorporation was 631 
visualized using the Click-iT EdU Kit (Invitrogen) according to the manufacturer’s instructions. 632 
Quantitative polymerase chain reaction (qPCR). For mouse OPC/OL mRNA analysis, RNA 633 
was extracted using Trizol (Invitrogen) and purified using the RNAeasy Kit (Qiagen) according 634 
to manufacturer’s instructions. Complementary DNA (cDNA) was generated using the High-635 
Capacity RNA-to-cDNA Kit (Applied Biosystems). qPCR was performed on a LightCycler 480 636 
using LightCycler 480 SYBR Green I Master mix, and melting curves were analyzed to ensure 637 
primer specificity. Mouse primers used included Kcnj10 (forward: AGAGGGCCGAGACGAT; 638 
reverse: TTGACCTGGTTGAGCCGAATA), Kcnj16 (forward: 639 
CCTGTGTCTCCTCTTGAAGG; reverse: TGTGCTTAGGTGATACAATACGG), Cacna1c 640 
(forward: CCTAATGGGTTCGTTTCAGAAGT; reverse: TCCGGTTACCTCCAGGTCA),  641 
Cdk1 (forward: GCCAGAGCGTTTGGAATACC; reverse: 642 
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CAGATGTCAACCGGAGTGGAGTA), Cdk2 (forward: GGCTCGACACTGAGACTGAA; 643 
reverse: GGTGCAGAAATTCAAAAACCA), Uhrf1 (forward: 644 
TGAAGCGGATGACAAGACTG; reverse: CAGGGCTCGTCCTCAGATAG), Nkx2-2 645 
(forward: GCCTCCAATACTCCCTGCAC; reverse: GTCATTGTCCGGTGACTCGT), Cnp 646 
(forward: GGCGGCCCCGGAGACATAGTA; reverse: GCTTGGGCAGGAATGTGTGGC), 647 
Mbp (forward: CCCAAGGCACAGAGACACGGG; reverse: 648 
TACCTTGCCAGAGCCCCGCTT) and 18s (forward: GTTCCGACCATAAACGATGCC; 649 
reverse: TGGTGGTGCCCTTCCGTCAAT). For normalization, mRNA expression levels were 650 
calculated according to ribosomal 18s expression and presented as relative mRNA levels 651 
throughout the figures. 652 
Western blot. Preparation of protein extracts, immunoblots and chemiluminescence detection 653 
was done as previously described(63). Fluorescent detection of proteins was carried out using the 654 
Li-Cor Odyssey system (Li-Cor) according to the manufacturer’s instructions. After blocking in 655 
PBS Odyssey Blocking Buffer (Li-Cor) for 1h at RT, primary antibodies were incubated 656 
overnight at 4°C. IRDye Goat anti-mouse and anti-rabbit (680 and 800) fluorescent secondary 657 
antibodies (Li-cor) were used for protein detection on the Odyssey Cxl imaging system. 658 
Antibodies. The following antibodies were used for immunopanning, immunocytochemistry, 659 
immunohistochemistry and Western Blot experiments: goat anti-OLIG2 (AF2418, R&D 660 
Systems, 1:50), mouse anti-APC (clone CC1, OP80, 1:300, Millipore Sigma), mouse anti-661 
NOGO-A (clone 11C7, gift from M.E. Schwab, 1:3,000), rat anti-MBP (ab7349, Abcam, 1:500), 662 
mouse anti-MOG (clone 8-18C5, 1:1,000, Millipore Sigma), rat anti-GFAP (clone 2.2B10, 13-663 
0300, Invitrogen, 1:1,000), rabbit anti-AQP4 (AB3594, 1:500, Millipore Sigma), rabbit anti-664 
KIR4.1 (APC035, Alomone Labs, 1:3,000), rabbit anti-KIR4.1 (APC-165, Alomone Labs, 665 
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1:1,000), rabbit anti-KIR5.1 (APC123, Alomone Labs, 1:500), mouse anti-Neurofilament H (NF-666 
H), nonphosphorylated (clone SMI32, 801701, Biolegend, 1:10,000), mouse anti-Neurofilament 667 
H (NF-H), phosphorylated (clone SMI312, 837904, Biolegend, 1:1,000), rabbit anti-IBA1 (019-668 
19741, Wako, 1:500), goat anti-BRN3a (sc-31984, Santa Cruz, 1:200), rabbit anti-KCNQ2 669 
(ab22897, Abcam, 1:200) rabbit anti-CASPR (ab34151, Abcam, 1:1,000), mouse anti-BRDU 670 
(347580, BD Biosciences, 1:200), rabbit anti-phospho-Histone H3 (pH3, 9701, Cell Signaling, 671 
1:500), rat anti-CD140a (558774, BD Biosciences, 1:500), mouse anti-β-ACTIN (A5316, Sigma, 672 
1:7,000). 673 
Image acquisition and analysis. Bright field images were acquired on a Zeiss Axio Imager 2 674 
microscope. Fluorescent images were taken using Leica TCS SP8 and TCS SPE laser confocal 675 
microscopes with either 10x, 20x, 40x or 63x objectives; all fluorescent pictures are Z-stack 676 
confocal images, unless stated otherwise. Images were processed using Fiji ImageJ or Photoshop 677 
software (Adobe) and exported to Illustrator vector-based software (Adobe) for figure 678 
generation. 679 
Statistical Analysis. Data are presented as mean ± SE of mean (SEM). Analyses was performed 680 
using two-tailed parametric or non-parametric (Mann-Whitney, Kruskal-Wallis) t-tests for two 681 
groups if applicable, one-way ANOVA with corresponding post-hoc tests for multiple group 682 
comparisons and paired two-way ANOVA with post-hoc tests for longitudinal group 683 
comparisons at different time points. Kaplan-Meier estimator was used to quantify survival rates 684 
between transgenic mice during aging. Level of significance was determined as described in the 685 
individual figure legends. P values were designated as follows: *P ≤ 0.5, **P ≤ 0.01, ***P ≤ 686 
0.001, ****P ≤ 0.0001. Analyses were performed using GraphPad Prism (GraphPad Software).  687 
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